Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

NeuroPace (NPCE) Gross Profit (2020 - 2025)

NeuroPace has reported Gross Profit over the past 6 years, most recently at $20.6 million for Q4 2025.

  • Quarterly results put Gross Profit at $20.6 million for Q4 2025, up 27.12% from a year ago — trailing twelve months through Dec 2025 was $77.2 million (up 30.69% YoY), and the annual figure for FY2025 was $77.2 million, up 30.69%.
  • Gross Profit for Q4 2025 was $20.6 million at NeuroPace, down from $21.2 million in the prior quarter.
  • Over the last five years, Gross Profit for NPCE hit a ceiling of $21.2 million in Q3 2025 and a floor of $7.5 million in Q2 2022.
  • Median Gross Profit over the past 5 years was $12.1 million (2023), compared with a mean of $12.5 million.
  • Peak annual rise in Gross Profit hit 72.64% in 2021, while the deepest fall reached 21.6% in 2021.
  • NeuroPace's Gross Profit stood at $8.1 million in 2021, then grew by 9.0% to $8.8 million in 2022, then surged by 53.87% to $13.5 million in 2023, then increased by 19.51% to $16.2 million in 2024, then increased by 27.12% to $20.6 million in 2025.
  • The last three reported values for Gross Profit were $20.6 million (Q4 2025), $21.2 million (Q3 2025), and $18.1 million (Q2 2025) per Business Quant data.